报告题目：Overcoming the Achilles' heel of photodynamic therapy
报告人：Dr. Xiaoyuan (Shawn) Chen
简历：Dr. Xiaoyuan (Shawn) Chen received his PhD in Chemistry from the University of Idaho (1999). After two postdocs at Syracuse University and Washington University in St. Louis, he started his Assistant Professorship in 2002 and then moved to Stanford in 2004. He moved to NIH in 2009 and became a Senior Investigator and Chief of the Laboratory of Molecular Imaging and Nanomedicine (LOMIN) at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. His current research interests include development of molecular imaging toolbox for better understanding of biology, early diagnosis of disease, monitoring therapy response, and guiding drug discovery/development. His lab puts special emphasis on high-sensitivity nanosensors for biomarker detection and theranostic nanomedicine for imaging, gene and drug delivery, and monitoring of treatment. Dr. Chen has published over 750 peer-reviewed papers (H-index = 128, total citations > 59,000 based on Google Scholar) and numerous books and book chapters. He is the founding editor of journal “Theranostics” (2017 IF = 8.537). He received Michael J. Welch, PhD Award (2019), was elected as AIMBE Fellow (2017), ACS Bioconjugate Chemistry Lecturer Award (2016), NIH Director’s Award (2014) and NIBIB Mentor Award (2012). He has served in the past as the President of Chinese-American Society of Nanomedicine and Nanobiotechnology (CASNN) and President of the Radiopharmaceutical Science Council (RPSC), Society of Nuclear Medicine and Molecular Imaging (SNMMI).